Amneal Pharmaceuticals, Inc. (AMRX)
17.69
+0.22
(+1.26%)
USD |
NASDAQ |
Sep 01, 16:00
17.69
0.00 (0.00%)
After-Hours: 16:17
Amneal Pharmaceuticals Cash from Investing (Quarterly) : -123.14M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -123.14M |
| March 31, 2026 | -21.71M |
| December 31, 2025 | -45.45M |
| September 30, 2025 | -22.46M |
| June 30, 2025 | -26.55M |
| March 31, 2025 | -17.80M |
| December 31, 2024 | -16.06M |
| September 30, 2024 | -20.71M |
| June 30, 2024 | -6.465M |
| March 31, 2024 | -19.76M |
| December 31, 2023 | -31.69M |
| September 30, 2023 | -13.48M |
| June 30, 2023 | -12.28M |
| March 31, 2023 | -11.74M |
| December 31, 2022 | -13.19M |
| September 30, 2022 | -49.33M |
| June 30, 2022 | -16.12M |
| March 31, 2022 | -97.40M |
| December 31, 2021 | -86.97M |
| September 30, 2021 | -11.63M |
| June 30, 2021 | -82.89M |
| March 31, 2021 | -12.69M |
| December 31, 2020 | -31.80M |
| September 30, 2020 | -18.08M |
| June 30, 2020 | -8.927M |
| Date | Value |
|---|---|
| March 31, 2020 | -262.04M |
| December 31, 2019 | -4.767M |
| September 30, 2019 | 29.98M |
| June 30, 2019 | -24.86M |
| March 31, 2019 | -23.48M |
| December 31, 2018 | 5.321M |
| September 30, 2018 | -52.55M |
| June 30, 2018 | -341.42M |
| March 31, 2018 | -19.50M |
| December 31, 2017 | -8.901M |
| September 30, 2017 | -35.04M |
| June 30, 2017 | -46.46M |
| March 31, 2017 | -8.15M |
| December 31, 2016 | -22.28M |
| September 30, 2016 | -597.15M |
| June 30, 2016 | 6.716M |
| March 31, 2016 | -14.38M |
| December 31, 2015 | -15.54M |
| September 30, 2015 | 55.15M |
| June 30, 2015 | -9.809M |
| March 31, 2015 | -497.34M |
| December 31, 2014 | 31.29M |
| September 30, 2014 | -1.672M |
| June 30, 2014 | -2.124M |
| March 31, 2014 | -44.09M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Liquidia Corp. | -12.24M |
| Eli Lilly & Co. | -15.40B |
| Viatris, Inc. | -51.60M |
| Pfizer Inc. | 2.106B |
| Indivior Pharmaceuticals, Inc. | -7.942M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -21.24M |
| Cash from Financing (Quarterly) | 79.76M |
| Free Cash Flow | -14.29M |
| Free Cash Flow Per Share (Quarterly) | -0.4388 |
| Free Cash Flow to Equity (Quarterly) | -239.26M |
| Free Cash Flow to Firm (Quarterly) | -90.01M |
| Free Cash Flow Yield | -0.25% |